Cresco Labs (CRLBF) Net Cash Flow Growth (1y) (2020 - 2025)
Cresco Labs (CRLBF) Net Cash Flow Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 179.67% |
| Sep 30, 2025 | -274.89% |
| Dec 31, 2024 | -247.81% |
| Sep 30, 2024 | 6.37% |
| Dec 31, 2023 | 58.78% |
| Sep 30, 2023 | -4.45% |
| Dec 31, 2022 | 62.35% |
| Sep 30, 2022 | -57.89% |
| Jun 30, 2022 | 44.01% |
| Mar 31, 2022 | -105.38% |
| Dec 31, 2021 | -135.44% |
| Sep 30, 2021 | 928.16% |
| Mar 31, 2021 | 590.34% |
| Dec 31, 2020 | 394.74% |